Retrieve available abstracts of 17 articles: HTML format
Single Articles
February 2025
ROMERO-VICO J, Vargas-Accarino E, Palom A, Fabrellas N, et al Utility of mobile applications in the management of hepatitis B: A systematic
review.
Gastroenterol Hepatol. 2025 Feb 19:502395. doi: 10.1016/j.gastrohep.2025.502395. PubMedAbstract available
January 2025
LUIS CASTRO URDA J, Alvarez M, Cantero H, Ayala V, et al The efficiency of artificial intelligence for management and clinical
decision-making in the identification of patients with undiagnosed HCV infection
(Intelligen-C strategy).
Gastroenterol Hepatol. 2025 Jan 18:502362. doi: 10.1016/j.gastrohep.2025.502362. PubMedAbstract available
FORNS X, Rodriguez M, Dominguez-Hernandez R, Cantero H, et al Cost analysis of hidden hepatitis D virus infection in Spain.
Gastroenterol Hepatol. 2025 Jan 8:502337. doi: 10.1016/j.gastrohep.2025.502337. PubMedAbstract available
December 2024
JIMENEZ-CASTILLO RA, Gonzalez-Martinez CE, Tovar-Bojorquez EM, Cortez-Hernandez CA, et al Prognostic value of relative adrenal insufficiency in patients with severe
alcohol-associated hepatitis-a prospective clinical study.
Gastroenterol Hepatol. 2024 Dec 12:502322. doi: 10.1016/j.gastrohep.2024.502322. PubMedAbstract available
November 2024
LOPEZ DE LA CRUZ J, Gonzalvo MCA, Ortiz de Solorzano Reig M, Aguilar A, et al Acute cholestatic hepatitis secondary to idiopathic adult ductopenia.
Gastroenterol Hepatol. 2024 Nov 14:502289. doi: 10.1016/j.gastrohep.2024.502289. PubMed
MIRALPEIX A, Ibanez P, Navarro V, Colomera P, et al Externalised nurse-led model for hepatitis C virus microelimination and impact of
drug use profile.
Gastroenterol Hepatol. 2024 Nov 13:502288. doi: 10.1016/j.gastrohep.2024.502288. PubMedAbstract available
October 2024
LUO JX, Chen G, Hu XY, Yu C, et al Tenofovir alafenamide versus entecavir in treating patients with chronic
hepatitis B: A meta-analysis.
Gastroenterol Hepatol. 2024 Oct 17:502276. doi: 10.1016/j.gastrohep.2024.502276. PubMedAbstract available
September 2024
BUTI M, Calleja JL, Rodriguez MA, Dominguez-Hernandez R, et al Clinical and economic value of bulevirtide in the treatment of chronic hepatitis
D.
Gastroenterol Hepatol. 2024 Sep 7:502241. doi: 10.1016/j.gastrohep.2024.502241. PubMedAbstract available
June 2024
BOLIS F, Cazzaniga G, Pagni F, Invernizzi P, et al The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis
variants.
Gastroenterol Hepatol. 2024 Jun 29:502225. doi: 10.1016/j.gastrohep.2024.502225. PubMedAbstract available
PARADA VAZQUEZ P, Perez-Cachafeiro S, Castineira Dominguez B, Gonzalez-Perez JM, et al Artificial intelligence-assisted identification and retrieval of chronic
hepatitis C patients lost to follow-up in the health area of Pontevedra and O
Salnes (Spain).
Gastroenterol Hepatol. 2024 Jun 29:502226. doi: 10.1016/j.gastrohep.2024.502226. PubMedAbstract available
RODRIGUEZ-TAJES S, Palom A, Giraldez Gallego A, Moreno A, et al Characterizing Hepatitis Delta in Spain and the gaps in its management.
Gastroenterol Hepatol. 2024 Jun 20:502222. doi: 10.1016/j.gastrohep.2024.502222. PubMedAbstract available
May 2024
ESTEBAN R, Hernandez RD, Cantero H, Casado MA, et al Evaluacion del valor clinico y economico de sofosbuvir/velpatasvir (SOF/VEL) en
pacientes con hepatitis C cronica en Espana durante los ultimos 5 anos.
Gastroenterol Hepatol. 2024 May 7:502199. doi: 10.1016/j.gastrohep.2024.502199. PubMedAbstract available
February 2024
JORQUERA F, Ledesma F, Ahumada A, Manzano ML, et al Clinical profile of Spanish hepatitis C virus-infected treatment-naive patients
with compensated cirrhosis in the CREST study.
Gastroenterol Hepatol. 2024 Feb 12:S0210-5705(24)00037. PubMedAbstract available
LIU Y, Chen S, Yu S, Wang J, et al LPS-TLR4 pathway exaggerates alcoholic hepatitis via provoking NETs formation.
Gastroenterol Hepatol. 2024;47:158-169. PubMedAbstract available
December 2023
CONTHE A, Ahumada A, Gallego Duran R, Marti-Aguado D, et al Current dilemmas in hepatitis virus C management. What should we do after
achieving sustained virologic response?
Gastroenterol Hepatol. 2023;46:826-829. PubMed
RIVEIRO-BARCIELA M, Roade L, Martinez-Camprecios J, Vidal-Gonzalez J, et al mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results
from the prospective collaborative CHES study (Chronic Hepatitis EScreening in
patients with immune impairment and increased transaminases levels).
Gastroenterol Hepatol. 2023;46:764-773. PubMedAbstract available
ARZALLUS T, Izagirre A, Castiella A, Torrente S, et al Drug induced autoimmune hepatitis after turmeric intake.
Gastroenterol Hepatol. 2023;46:805-806. PubMed